In vitro modeling of the neurovascular unit: advances in the field

The blood–brain barrier (BBB) is a fundamental component of the central nervous system. Its functional and structural integrity is vital in maintaining the homeostasis of the brain microenvironment. On the other hand, the BBB is also a major hindering obstacle for the delivery of effective therapies to treat disorders of the Central Nervous System (CNS). Over time, various model systems have been established to simulate the complexities of the BBB. The development of realistic in vitro BBB models that accurately mimic the physiological characteristics of the brain microcapillaries in situ is of fundamental importance not only in CNS drug discovery but also in translational research. Successful modeling of the Neurovascular Unit (NVU) would provide an invaluable tool that would aid in dissecting out the pathological factors, mechanisms of action, and corresponding targets prodromal to the onset of CNS disorders. The field of BBB in vitro modeling has seen many fundamental changes in the last few years with the introduction of novel tools and methods to improve existing models and enable new ones. The development of CNS organoids, organ-on-chip, spheroids, 3D printed microfluidics, and other innovative technologies have the potential to advance the field of BBB and NVU modeling. Therefore, in this review, summarize the advances and progress in the design and application of functional in vitro BBB platforms with a focus on rapidly advancing technologies.

[1]  Tânia Cova,et al.  Computational modeling in glioblastoma: from the prediction of blood-brain barrier permeability to the simulation of tumor behavior. , 2018, Future medicinal chemistry.

[2]  Joshua M. Pearce,et al.  Mechanical properties of components fabricated with open-source 3-D printers under realistic environmental conditions , 2014 .

[3]  R. Deane,et al.  RAGE (Yin) Versus LRP (Yang) Balance Regulates Alzheimer Amyloid &bgr;-Peptide Clearance Through Transport Across the Blood–Brain Barrier , 2004, Stroke.

[4]  Farzane Sivandzade,et al.  Cerebrovascular and Neurological Disorders: Protective Role of NRF2 , 2019, International journal of molecular sciences.

[5]  O. Langer,et al.  Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model , 2019, Scientific Reports.

[6]  Y. Jiao,et al.  Acute Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or Paraquat on Core Temperature in C57BL/6J Mice , 2015, Journal of Parkinson's disease.

[7]  Ronak Patel,et al.  Isogenic blood–brain barrier models based on patient‐derived stem cells display inter‐individual differences in cell maturation and functionality , 2017, Journal of neurochemistry.

[8]  Mohammad F. Kiani,et al.  A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip , 2015, PloS one.

[9]  Martin L. Dunn,et al.  Active origami by 4D printing , 2014 .

[10]  Sonia Grego,et al.  An optically transparent membrane supports shear stress studies in a three-dimensional microfluidic neurovascular unit model. , 2015, Biomicrofluidics.

[11]  Liwei Lin,et al.  3D printed microfluidics and microelectronics , 2018 .

[12]  Chee Kai Chua,et al.  Fundamentals and applications of 3D printing for novel materials , 2017 .

[13]  Sukant Khurana,et al.  Evaluation of Models of Parkinson's Disease , 2016, Front. Neurosci..

[14]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[15]  L. Kappelle,et al.  Early complications of ischemic stroke. , 2008, Current treatment options in neurology.

[16]  W. Moon,et al.  Gadolinium Deposition in the Brain: Current Updates , 2018, Korean journal of radiology.

[17]  Sean P. Palecek,et al.  Efficient Differentiation of Human Pluripotent Stem Cells to Endothelial Progenitors via Small-Molecule Activation of WNT Signaling , 2014, Stem cell reports.

[18]  T. Kuroiwa,et al.  The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion , 2004, Acta Neuropathologica.

[19]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[20]  M. Shuler,et al.  Microfluidic blood–brain barrier model provides in vivo‐like barrier properties for drug permeability screening , 2017, Biotechnology and bioengineering.

[21]  A. Seyfoori,et al.  In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Sean P. Palecek,et al.  Modeling the blood–brain barrier using stem cell sources , 2013, Fluids and Barriers of the CNS.

[23]  A. Atala,et al.  Human Cortex Spheroid with a Functional Blood Brain Barrier for High-Throughput Neurotoxicity Screening and Disease Modeling , 2018, Scientific Reports.

[24]  B. Lacoste,et al.  Impact of Metabolic Syndrome on Neuroinflammation and the Blood–Brain Barrier , 2018, Front. Neurosci..

[25]  K. Dawson,et al.  Reproducibility in biological models of the blood-brain barrier , 2014 .

[26]  Maxime Culot,et al.  A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells , 2014, PloS one.

[27]  I. Wilhelm,et al.  In vitro models of the blood-brain barrier for the study of drug delivery to the brain. , 2014, Molecular pharmaceutics.

[28]  Ivan Mihaljevic,et al.  Amyloid-&bgr; Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy , 2012, Stroke.

[29]  T. Terasaki,et al.  Fluids and Barriers of the Cns , 2022 .

[30]  Impact of cigarette smoke extract and hyperglycemic conditions on blood–brain barrier endothelial cells , 2015, Fluids and Barriers of the CNS.

[31]  N. Abbott Blood–brain barrier structure and function and the challenges for CNS drug delivery , 2013, Journal of Inherited Metabolic Disease.

[32]  D. Howland,et al.  Mind the gap: Models in multiple species needed for therapeutic development in Huntington's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[33]  Donald E. Ingber,et al.  Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip , 2016, PloS one.

[34]  S. Gerecht,et al.  Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D , 2019, Fluids and Barriers of the CNS.

[35]  Dong Wang,et al.  Glucose Transporter Type 1 Deficiency Syndrome , 2015 .

[36]  SaariMatt,et al.  Fiber Encapsulation Additive Manufacturing: An Enabling Technology for 3D Printing of Electromechanical Devices and Robotic Components , 2015 .

[37]  Hanseup Kim,et al.  Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.

[38]  R. Candler,et al.  3D printed molds for non-planar PDMS microfluidic channels , 2015 .

[39]  Mark Platt,et al.  3D printed microfluidic device with integrated optical sensing for particle analysis , 2018 .

[40]  J. Kang,et al.  Collagen-based brain microvasculature model in vitro using three-dimensional printed template. , 2015, Biomicrofluidics.

[41]  M. Birtwistle,et al.  Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials. , 2017, ACS chemical neuroscience.

[42]  R. Jayant,et al.  In-vitro blood-brain barrier models for drug screening and permeation studies: an overview , 2019, Drug design, development and therapy.

[43]  B. Bax,et al.  Organs to Cells and Cells to Organoids: The Evolution of in vitro Central Nervous System Modelling , 2019, Front. Cell. Neurosci..

[44]  Tuan Ngo,et al.  Bimaterial 3D printing and numerical analysis of bio-inspired composite structures under in-plane and transverse loadings , 2017 .

[45]  Luca Cucullo,et al.  New experimental models of the blood-brain barrier for CNS drug discovery , 2017, Expert opinion on drug discovery.

[46]  Zhen Gao,et al.  Predict drug permeability to blood‐brain‐barrier from clinical phenotypes: drug side effects and drug indications , 2016, Bioinform..

[47]  W. Neuhaus Human induced pluripotent stem cell based in vitro models of the blood-brain barrier: the future standard? , 2017, Neural Regeneration Research.

[48]  M. Wendland,et al.  Blood–Brain Barrier Permeability Is Increased After Acute Adult Stroke But Not Neonatal Stroke in the Rat , 2012, The Journal of Neuroscience.

[49]  Stefan Aigner,et al.  Multicellular Self-Assembled Spheroidal Model of the Blood Brain Barrier , 2013, Scientific Reports.

[50]  Maxime Culot,et al.  Modelling of the blood–brain barrier in drug discovery and development , 2007, Nature Reviews Drug Discovery.

[51]  H. D. de Vries,et al.  The blood-brain barrier in multiple sclerosis: microRNAs as key regulators. , 2015, CNS & neurological disorders drug targets.

[52]  R. Jain,et al.  The biology of brain metastases—translation to new therapies , 2011, Nature Reviews Clinical Oncology.

[53]  Joshua J. Breunig,et al.  Organoid and Organ-on-a-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease , 2017, Current Stem Cell Reports.

[54]  T. Sobrino,et al.  Multifunctional Superparamagnetic Stiff Nanoreservoirs for Blood Brain Barrier Applications , 2019, Nanomaterials.

[55]  A. Fine,et al.  Launching invasive, first‐in‐human trials against Parkinson's disease: Ethical considerations , 2009, Movement disorders : official journal of the Movement Disorder Society.

[56]  I. Sherman,et al.  Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. , 1996, International journal for parasitology.

[57]  P. Couraud,et al.  Instruction of Circulating Endothelial Progenitors In Vitro towards Specialized Blood-Brain Barrier and Arterial Phenotypes , 2014, PloS one.

[58]  Susan T Francis,et al.  Cerebrovascular and blood–brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology , 2015, Annals of neurology.

[59]  Lingyan Shi,et al.  Quantification of blood-brain barrier solute permeability and brain transport by multiphoton microscopy. , 2014, Journal of biomechanical engineering.

[60]  Roger D. Kamm,et al.  A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier. , 2017, Lab on a chip.

[61]  J. Li,et al.  Mild hypothermia alleviates brain oedema and blood-brain barrier disruption by attenuating tight junction and adherens junction breakdown in a swine model of cardiopulmonary resuscitation , 2017, PloS one.

[62]  T. Kanda,et al.  Blood–brain barrier dysfunction in immuno-mediated neurological diseases , 2018, Immunological medicine.

[63]  M. Waldner,et al.  Permeability analyses and three dimensional imaging of interferon gamma-induced barrier disintegration in intestinal organoids. , 2019, Stem cell research.

[64]  R. Keep,et al.  Junctional proteins of the blood-brain barrier: New insights into function and dysfunction , 2016, Tissue barriers.

[65]  Colin M. Fadzen,et al.  Blood–brain-barrier organoids for investigating the permeability of CNS therapeutics , 2018, Nature Protocols.

[66]  Z. Cai,et al.  Role of Blood-Brain Barrier in Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.

[67]  F. Yuan,et al.  A review of three-dimensional in vitro tissue models for drug discovery and transport studies. , 2011, Journal of pharmaceutical sciences.

[68]  Sean P. Palecek,et al.  Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies , 2019, Nature Communications.

[69]  B. Waldau,et al.  Generation of human vascularized brain organoids , 2018, Neuroreport.

[70]  Nathalie Y. R. Agar,et al.  Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents , 2017, Nature Communications.

[71]  Xin Wang,et al.  3D printing of polymer matrix composites: A review and prospective , 2017 .

[72]  J. Lahann,et al.  A microfluidic model of human brain (μHuB) for assessment of blood brain barrier , 2019, Bioengineering & translational medicine.

[73]  R. Deane,et al.  ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration , 2008, Nature Neuroscience.

[74]  J. Cuevas,et al.  A modular approach to create a neurovascular unit-on-a-chip. , 2013, Lab on a chip.

[75]  I. Fidler The role of the organ microenvironment in brain metastasis. , 2011, Seminars in cancer biology.

[76]  A. Easton,et al.  Two components of blood‐brain barrier disruption in the rat , 1997, The Journal of physiology.

[77]  Shihua Li,et al.  Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy , 2015, Drug design, development and therapy.

[78]  Chee Meng Benjamin Ho,et al.  3D printed microfluidics for biological applications. , 2015, Lab on a chip.

[79]  M. D'Esposito,et al.  Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease , 2017, Scientific Reports.

[80]  B. Fu,et al.  Non-invasive measurement of solute permeability in cerebral microvessels of the rat. , 2009, Microvascular research.

[81]  Clive N Svendsen,et al.  Human iPSC-Derived Blood-Brain Barrier Chips Enable Disease Modeling and Personalized Medicine Applications. , 2019, Cell stem cell.

[82]  Edward J. Rapp,et al.  Immortalized Human Brain Endothelial Cells and Flow-Based Vascular Modeling: A Marriage of Convenience for Rational Neurovascular Studies , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  M. Danhof,et al.  Drug transport across the blood-brain barrier , 1992, Pharmaceutisch Weekblad.

[84]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[85]  C. Rosen,et al.  Spinal cord injury Injury to any part of the spinal cord that leads to inflammation and secondary effects on the CNS Spinal impact model , 2015 .

[86]  Andrey A Toropov,et al.  QSAR model for blood-brain barrier permeation. , 2017, Journal of pharmacological and toxicological methods.

[87]  I. Wilhelm,et al.  In vitro models of the blood-brain barrier. , 2011, Acta neurobiologiae experimentalis.

[88]  B. Ballermann,et al.  Adhesion and differentiation of endothelial cells by exposure to chronic shear stress: a vascular graft model. , 1995, Blood purification.

[89]  Ramille N Shah,et al.  3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression. , 2018, Acta biomaterialia.

[90]  Shuichi Takayama,et al.  Organization of Endothelial Cells, Pericytes, and Astrocytes into a 3D Microfluidic in Vitro Model of the Blood-Brain Barrier. , 2016, Molecular pharmaceutics.

[91]  M. Khan,et al.  A new chapter in pharmaceutical manufacturing: 3D‐printed drug products☆, ☆☆ , 2017, Advanced drug delivery reviews.

[92]  Yao Yao,et al.  Basement membrane and blood–brain barrier , 2018, Stroke and Vascular Neurology.

[93]  Wei Zhu,et al.  3D optical printing of piezoelectric nanoparticle-polymer composite materials. , 2014, ACS nano.

[94]  P. Couraud,et al.  The hCMEC/D3 cell line as a model of the human blood brain barrier , 2013, Fluids and Barriers of the CNS.

[95]  Luca Cucullo,et al.  In vitro blood-brain barrier models: current and perspective technologies. , 2012, Journal of pharmaceutical sciences.

[96]  Eunhee Kim,et al.  Blood–Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease , 2019, Advanced science.

[97]  K. Engelstad,et al.  Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) , 2013, Current Neurology and Neuroscience Reports.

[98]  K. Kulp,et al.  A Reconfigurable In Vitro Model for Studying the Blood–Brain Barrier , 2019, Annals of Biomedical Engineering.

[99]  L. Khawli,et al.  Vascular physiology and protein disposition in a preclinical model of neurodegeneration. , 2013, Molecular pharmaceutics.

[100]  Amid Shakeri,et al.  Fabricating smooth PDMS microfluidic channels from low-resolution 3D printed molds using an omniphobic lubricant-infused coating. , 2018, Analytica chimica acta.

[101]  H. Galla,et al.  Monocultures of primary porcine brain capillary endothelial cells: Still a functional in vitro model for the blood‐brain‐barrier , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[102]  Marinella Levi,et al.  Conductive 3D microstructures by direct 3D printing of polymer/carbon nanotube nanocomposites via liquid deposition modeling , 2015 .

[103]  Qing Yang,et al.  Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. , 2015, Biomicrofluidics.

[104]  Jia Li,et al.  Inkjet printing for biosensor fabrication: combining chemistry and technology for advanced manufacturing. , 2015, Lab on a chip.

[105]  Xinyu Zhao,et al.  Adult neural stem cells: response to stroke injury and potential for therapeutic applications. , 2011, Current stem cell research & therapy.

[106]  M. Kaps,et al.  Changes in CSF blood-brain barrier parameters in ischaemic cerebral infarction , 2004, Journal of Neurology.

[107]  P. Grammas A damaged microcirculation contributes to neuronal cell death in Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[108]  H. Wolburg,et al.  Brain endothelial cells and the glio-vascular complex , 2008, Cell and Tissue Research.

[109]  Z. Cui,et al.  3D-printed thick structured gelatin membrane for engineering of heterogeneous tissues , 2018 .

[110]  Walter H Backes,et al.  Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease. , 2017, Radiology.

[111]  K. M. Baeten,et al.  Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke , 2011, Developmental neurobiology.

[112]  K. Zahs,et al.  ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? , 2010, Trends in Neurosciences.

[113]  A J Thompson,et al.  A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.

[114]  M. Mayberg,et al.  A new dynamic in vitro model for the multidimensional study of astrocyte–endothelial cell interactions at the blood–brain barrier , 2002, Brain Research.

[115]  N. Williams,et al.  Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia , 2017, Molecular Psychiatry.

[116]  L. Cucullo,et al.  In Vitro Cerebrovascular Modeling in the 21st Century: Current and Prospective Technologies , 2014, Pharmaceutical Research.

[117]  Arthur W. Toga,et al.  Brain imaging of neurovascular dysfunction in Alzheimer’s disease , 2016, Acta Neuropathologica.

[118]  E. Aronica,et al.  Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. , 2007, Brain : a journal of neurology.

[119]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[120]  Andrea Ehrmann,et al.  3D printing of textile-based structures by Fused Deposition Modelling (FDM) with different polymer materials , 2014 .

[121]  Luca Cucullo,et al.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. , 2014, Journal of pharmacovigilance.

[122]  D. Janigro,et al.  A Dynamic in vitro BBB Model for the Study of Immune Cell Trafficking into the Central Nervous System , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[123]  Pál Ormos,et al.  A versatile lab-on-a-chip tool for modeling biological barriers , 2016 .

[124]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[125]  A. Minagar,et al.  Vascular pathology of multiple sclerosis , 2012, Neurological research.

[126]  Kapil Pant,et al.  SyM-BBB: a microfluidic Blood Brain Barrier model. , 2013, Lab on a chip.

[127]  Sean P. Palecek,et al.  Modeling Psychomotor Retardation using iPSCs from MCT8-Deficient Patients Indicates a Prominent Role for the Blood-Brain Barrier. , 2017, Cell stem cell.

[128]  Takashi Suzuki,et al.  Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors , 2011, Journal of neurochemistry.

[129]  R. Wilensky,et al.  Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib. , 2013, Journal of Alzheimer's disease : JAD.

[130]  Walter H. Backes,et al.  Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging , 2016, Neurobiology of Aging.

[131]  P. Searson,et al.  Tissue-engineered blood-brain barrier models via directed differentiation of human induced pluripotent stem cells , 2019, Scientific Reports.

[132]  P. Galie,et al.  Mechanical stress regulates transport in a compliant 3D model of the blood-brain barrier. , 2017, Biomaterials.

[133]  D. Agoston Bench-to-Bedside and Bedside Back to the Bench; Seeking a Better Understanding of the Acute Pathophysiological Process in Severe Traumatic Brain Injury , 2015, Front. Neurol..

[134]  Eric V Shusta,et al.  In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[135]  C. A. Shaji,et al.  A Mouse Controlled Cortical Impact Model of Traumatic Brain Injury for Studying Blood-Brain Barrier Dysfunctions. , 2018, Methods in molecular biology.

[136]  T. Kanda,et al.  Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood–brain barrier function , 2010, Journal of cellular physiology.

[137]  Maria João Gomes,et al.  Cell-based in vitro models for studying blood–brain barrier (BBB) permeability , 2016 .

[138]  Shlomo Magdassi,et al.  3D printing of porous structures by UV-curable O/W emulsion for fabrication of conductive objects , 2015 .

[139]  M. Stins,et al.  Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. , 2001, Microbial pathogenesis.

[140]  Berislav V. Zlokovic,et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.

[141]  R. Deane,et al.  The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. , 2008, Current pharmaceutical design.

[142]  B. Zlokovic,et al.  Pericytes of the neurovascular unit: key functions and signaling pathways , 2016, Nature Neuroscience.

[143]  Farzane Sivandzade,et al.  NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches , 2018, Redox biology.

[144]  M. Hayden,et al.  Choosing an animal model for the study of Huntington's disease , 2013, Nature Reviews Neuroscience.

[145]  Varlei Rodrigues,et al.  Simplified fabrication of integrated microfluidic devices using fused deposition modeling 3D printing , 2017 .

[146]  H. Pakkenberg,et al.  MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study. , 1999, Neurotoxicology and teratology.

[147]  M. Brug,et al.  Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies , 2015, Neuron.

[148]  Max I Bogorad,et al.  Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior. , 2019, Biomaterials.

[149]  Malcolm Macleod,et al.  How can we improve the pre-clinical development of drugs for stroke? , 2007, Trends in Neurosciences.

[150]  Lihong Liu,et al.  Modern methods for delivery of drugs across the blood-brain barrier. , 2012, Advanced drug delivery reviews.

[151]  Luca Cucullo,et al.  The role of shear stress in Blood-Brain Barrier endothelial physiology , 2011, BMC Neuroscience.

[152]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[153]  Gabriela Constantin,et al.  The blood-brain barrier in Alzheimer's disease , 2017, Neurobiology of Disease.

[154]  P. Ronaldson,et al.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. , 2018, American journal of physiology. Cell physiology.

[155]  A. Butt Effect of inflammatory agents on electrical resistance across the blood-brain barrier in pial microvessels of anaesthetized rats , 1995, Brain Research.

[156]  Roger D Kamm,et al.  3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes. , 2018, Biomaterials.

[157]  C. Betsholtz,et al.  Rate of small‐molecular drug transport across the blood‐brain barrier in a pericyte‐deficient state , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[158]  H. Blau,et al.  Nuclear reprogramming to a pluripotent state by three approaches , 2010, Nature.